Holen Sie sich die Stockscreener-App
6.70
3.18%
-0.22
Finanzdaten der Starling Oncology, Inc. Common Stock-Aktie (STLN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
9.39%
161.28
|
147.44 | 141.96 | 136.56 | 119.80 |
| Selling, General, and Administrative |
6.14%
29.94
|
28.21 | 28.04 | 25.25 | 26.91 |
| Depreciation and Amortization |
13.74%
1.838
|
1.616 | 1.632 | 1.723 | 1.805 |
| Operating Income/Loss |
29.13%
-4.616
|
-6.513 | -6.907 | -8.054 | -11.21 |
| Nonoperating Income/Loss |
228.65%
-5.173
|
4.021 | -0.601 | -8.45 | -5.929 |
| Income/Loss From Continuing Operations Before Tax |
292.82%
-9.789
|
-2.492 | -7.508 | -16.50 | -17.14 |
| Income Tax Expense/Benefit |
-
|
- | - | - | -0.131 |
Net Income/Loss
|
292.82%
-9.789
|
-2.492 | -7.508 | -16.50 | -17.01 |
| Basic Average Shares |
1.21%
103.03
|
101.80 | - | 97.47 | 93.20 |
| Diluted Average Shares |
1.21%
103.03
|
101.80 | - | 97.47 | 93.20 |
| Basic Earnings Per Share |
300.00%
-0.08
|
-0.02 | - | -0.14 | -0.15 |
| Diluted Earnings Per Share |
300.00%
-0.08
|
-0.02 | - | -0.14 | -0.15 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
288.94%
-1.548
|
-0.398 | -1.081 | -2.734 | -3.018 |
0.09%
2.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):